Shopping Cart
- Remove All
- Your shopping cart is currently empty
CAY10726 is an arylurea fatty acid. It decreases ATP production by 28% in MDA-MB-231 breast cancer cells when used at a concentration of 10 μM. CAY10726 decreases proliferation and initiates apoptosis in MDA-MB-231 cells via depletion of the phospholipid cardiolipin and its precursor phosphatidylglycerol from the mitochondrial membrane.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $78 | 35 days | |
5 mg | $348 | 35 days | |
10 mg | $595 | 35 days | |
25 mg | $1,330 | 35 days |
Description | CAY10726 is an arylurea fatty acid. It decreases ATP production by 28% in MDA-MB-231 breast cancer cells when used at a concentration of 10 μM. CAY10726 decreases proliferation and initiates apoptosis in MDA-MB-231 cells via depletion of the phospholipid cardiolipin and its precursor phosphatidylglycerol from the mitochondrial membrane. In vivo, CAY10726 (2.5-40 mg/kg) reduces tumor volume and increases tumor cell apoptosis in a mouse MDA-MB-231 breast cancer xenograft model in a dose-dependent manner. |
In vivo | In vivo, CAY10726 (2.5-40 mg/kg) reduces tumor volume and increases tumor cell apoptosis in a mouse MDA-MB-231 breast cancer xenograft model in a dose-dependent manner. |
Alias | CAY10726 |
Molecular Weight | 493 |
Formula | C24H36ClF3N2O3 |
Cas No. | 1611446-66-2 |
Relative Density. | 1.176 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: 5 mg/mL Ethanol: 12 mg/mL DMF:PBS(pH7.2) (1:2): 0.33 mg/mL DMF: 20 mg/mL |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.